NASDAQ
Helix BioMedix, Inc. (HXBM) has a current ratio of 12.16x as of Monday, May 25, 2026. This represents a 67.16% decrease compared to its 12-month average of 37.04x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.